<DOC>
	<DOCNO>NCT01557270</DOCNO>
	<brief_summary>The purpose study test efficacy safety dexmedetomidine add ropivacaine patient undergo shoulder surgery .</brief_summary>
	<brief_title>Efficacy Safety Study Dexmedetomidine Additive Local Anesthetics Shoulder Surgery</brief_title>
	<detailed_description>Peripheral nerve block use throughout world lieu general anesthesia , commonly , provide analgesia opioid spar postoperative course . Long act local anesthetic , ropivacaine , provide analgesia 11.5 Â± 5 hour . This lead many patient report first pain evening nighttime hour access healthcare provider support limit . A number additives local anesthetic study human limited success . Recent work group Michigan find dose dependent increase duration analgesia thermal stimulus dexmedetomidine add ropivacaine sciatic nerve block rat . The goal study investigate safety efficacy dexmedetomidine add ropivacaine interscalene brachial plexus nerve block shoulder surgery human . Provided initial safety establish , trial continue evaluate secondary goal include duration analgesia , onset sensory motor blockade , opioid-induced side effect . Tertiary outcome include subject satisfaction .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>ASA IIII adult subject Age 1875 Elective shoulder surgery Plan interscalene brachial plexus block combine general anesthesia Interscalene block Willingness contact postoperatively brief ( 510min ) phone call questionnaire Written inform consent Age &lt; 18 Age &gt; 75 Inability understand protocol due language barrier ; difficulty German language Chronic pain require daily opioids &gt; 15 mg oral morphine equivalent ( equal oral usage &gt; 10 mg oxycodone/daily ; &gt; 5 mg methadone/day ; &gt; 4 mg hydromorphone/day ) Moderate ( NRS pain score &gt; 5 ) daily average pain Daily use gabapentin , pregabalin , tricyclic antidepressant , serotonin norepinephrine reuptake inhibitor , tramadol Hypersensitivity amide local anesthetic History hypersensitivity allergic reaction clonidine dexmedetomidine Uncontrolled anxiety Schizophrenia bipolar disorder Preexisting nerve damage ( sensory motor ) extremity block Peripheral neuropathy Significant cardiovascular disease ( second ( Mobitz II type ) third degree heart block , congestive heart failure , chronic heart failure NYHA IIIIV , symptomatic coronary artery disease CSS IIIIV ) BMI &gt; 35 Uncontrolled diabetes ( blood sugar &gt; 250 record last 30 day HbA1c &gt; 7.5 % ) Chronic clonidine therapy ( clonidine patch Catapres clonidine tablet ) Hepatic Impairment ( CHILD B high ) Renal Impairment ( creatinin &gt; 2.0 mg/dl ) Ongoing drug alcohol abuse Pregnancy Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>